COPENHAGEN, Oct 31 (Reuters) - Novo Nordisk

has notified employees impacted by the drugmaker's job cuts in

the vast majority of its locations although the pace varies

according to local laws, its CEO Mike Doustdar wrote in a post

on LinkedIn on Friday.

Doustdar launched a restructuring drive last month,

including 9,000 job cuts globally as Novo faces heated

competition in the United States, the world's biggest drug

market, against rival Eli Lilly ( LLY ).

(Reporting by Stine Jacobsen, writing by Louise Breusch

Rasmussen, editing by)